Search
Confirm
Cancel
Language   navlogo
Investor relations

Investor relations

All categories
Company files
Financial reports
Company reports
Share price and share documentations
Investor relations
Location:
Homepage
/
Company reports
VOLUNTARY ANNOUNCEMENT 'ACETYLCYSTEINE EFFERVESCENT TABLET' APPROVED FOR MARKETING
2024-12-07
Categories:
Company reports
File size:
77KB
下载
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
2024-09-06
Categories:
Company reports
File size:
953KB
下载
VOLUNTARY ANNOUNCEMENT APPLICATION FOR LAUNCHING 'MEASARTAN POTASSIUM TABLETS' BEING ACCEPTED
2024-09-06
Categories:
Company reports
File size:
73KB
下载
VOLUNTARY ANNOUNCEMENT APPLICATION FOR LAUNCHING BEING ACCEPTED
2024-08-09
Categories:
Company reports
File size:
75KB
下载
VOLUNTARY ANNOUNCEMENT APPLICATION FOR LAUNCHING ENZALUTAMIDE SOFT CAPSULES BEING ACCEPTED
2024-06-06
Categories:
Company reports
File size:
75KB
下载
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2024
2024-06-06
Categories:
Company reports
File size:
58KB
下载
NOTICE OF ANNUAL GENERAL MEETING
2024-05-06
Categories:
Company reports
File size:
88KB
下载
VOLUNTARY ANNOUNCEMENT APPLICATION FOR LAUNCHING _METFORMIN EMPAGLIFLOZIN TABLETS (I)_ ACCEPTED
2024-04-07
Categories:
Company reports
File size:
73KB
下载
Page up
1
2
...
10
Home
About us
Company profile History Organizational Chart Culture Honors
News
Company News Industry News Media Information
Products
Category of heat clearing and detoxification Category of cardio cerebrovascular category Category of reducing blood pressure and sugar Category of tonifying Category of regulating qi Category of anti-anemia Category of antibacterial and anti-inflammatory Category of gastrointestinal tract Category of expectorant cough
Investor relations
Company files Financial reports Company reports Share price and share documentations Investor relations
Products R&D
Join us
Contact us

WeChat

福森药业

Copyright © 2021 Fusen Pharmaceutical Company Limited

豫ICP备2021028871号  Powered by www.300.cn

Copyright © 2021 Fusen Pharmaceutical  All Rights Reserved.      豫ICP备2021028871号        Powered by www.300.cn